Stock Analysis Β· Bulls vs Bears

Real REMAX Group REAX

πŸ‚ Bulls vs Bears 🐻Report #17 Oct 2026
β˜… Willem owns this stock Β· 4.4% of the portfolioOlder version β€” see the latest β†’
68
high risk
β€”
30%
β–² Chance of the biggest tailwind the forecasts miss
35%
β–Ό Chance of the biggest headwind the forecasts miss
The Bulls vs Bears podcast is being made
Two AI hosts debate this report, NotebookLM-style. It appears here automatically within a few hours.

Written by Claude (Anthropic’s AI) from public sources Β· Willem owns REAX Β· AI can make mistakes β€” numbers in brackets point to the sources Β· Not financial advice

Bull case

  1. Real growth engine: Q2 revenue +30%, closed sides +27%, volume $26.3B (+31%), adj. opex per deal βˆ’19%.
  2. Margin mix: adding ~$94M of 32%-margin franchise EBITDA.
  3. Synergies: $30M run-rate (β‰ˆ19% of pro forma EBITDA), majority in calendar 2027 (one filing says by end of year 2; Q2 call says within 3 years β€” inconsistent).
  4. Valuation: ~0.5x pro forma sales, ~7x pro forma adj. EBITDA; sell-side targets $35–40 (JonesTrading Buy $40 maintained 2026-09-15; BTIG $35).
  5. Buyback: authorized up to $450M/25M shares; at <$20 each 1M shares retired β‰ˆ 2.8% of count.
  6. Housing "near trough": any recovery leverages 8–9% gross margin to a growing agent base.
  7. 25 hedge funds held at end of Q2 (up from 21).

Devil's advocate on the bull case

  1. Growth: some agent growth is bought through equity/revenue-share incentives; Q1 revenue still missed; gross margin slipped 9.6β†’9.1% on capped agents.
  2. Margin mix: RE/MAX EBITDA is falling (βˆ’12.6% Q2) and US agents βˆ’4.6%; the 32% margin pool is eroding.
  3. Synergies: management-defined, cost-only, with conflicting timing; integration cost (Q2 deal cost $11.6M already) could eat them.
  4. Valuation: adj. EBITDA adds back SBC; GAAP net losses; 7x on a shrinking base isn't cheap.
  5. Targets: analysts at $35–40 pre-date much of the drop (and some feeds are stale/split-inconsistent).
  6. Buyback: cash is tied to debt paydown; doing both is impossible at 3.5x leverage; the authorisation is optional.
  7. Hedge fund count: crowded-ish small cap; a Wasatch long/short fund was short.

Bear case

  1. Leverage ~3.5x gross on a cyclical, with $550M secured term loan (β‰ˆ93% of market cap).
  2. RE/MAX shrinkage: revenue βˆ’5.8%, EBITDA βˆ’12.6% in Q2; US/Canada agents βˆ’4.6% FY25.
  3. Quality of earnings: Real GAAP op loss βˆ’$7.0M Q2'26 vs adj. EBITDA +$27.6M.
  4. Stock βˆ’62% y/y; 31% fall in the month to Sep 15; βˆ’12.9% on proration news.
  5. Overhang: cash/stock election mix and share consolidation create technical selling; share-count reports in sources conflict (21.8M–36.3M).
  6. AI disruption narrative and commission-structure shifts.
  7. Integration of two cultures; retention of legacy franchisees who are sensitive to Real's revenue-share model.

Counter-arguments to the bear case

  1. Leverage: targets <2.0x within ~2 years; interest cover ~4x on $157M vs ~$40M interest (assumption) β€” medium.
  2. RE/MAX shrinkage: priced in at ~6–7x; Real's tech/agent growth can offset β€” medium.
  3. Earnings quality: Real's operating cash flow was positive $47.2M in Q2 and $23.3M in Q1 β€” medium.
  4. Price decline: already at 52-week low; implies low expectations β€” weak (momentum persistent).
  5. Technical overhang: transitory by nature β€” medium.
  6. AI: agents hold the transaction trust/licensing role; Real's AI tooling reduces opex β€” weak–medium (unproven).
  7. Integration: separate brands and sizeable synergy reserve of cost β€” weak (no track record).

Unpriced tailwinds

Tailwind Why not in consensus/price % chance in 36M Value impact
Housing-turnover recovery (rates) Market assumes trough persists 40% +$8–12/share at +$30M EBITDA
Synergies beat $30M Mgmt says "high confidence" but unproven 25% +$3–5/share
Cross-sell (title, mortgage, wallet) to 180K agents Tiny revenue today 20% +$2–4/share
Buyback at depressed prices Debt priority 30% +$2–4/share

Unpriced headwinds

Headwind Why not priced % chance in 36M Impact
RE/MAX attrition accelerates Hard to model, franchisees can leave 35% βˆ’$4–8/share
Covenant/refi stress at 4.5x+ Market assumes deleveraging 15% βˆ’$8–12/share
Commission/legal change reducing take rate Ongoing litigation backdrop 20% βˆ’$3–6/share
Equity-comp dilution Hidden in adj. EBITDA 50% βˆ’$1–3/share

Snapshot & business overview

  • Real (REAX legacy): agent-owned, tech-enabled brokerage with revenue share and equity plans; also Real Wallet (Q1'26 rev $436K, +~250%), One Real Title (Q1'26 rev $1.3M, +22%). Agents 35,348 (Q2'26, +26%); churn Q1'26: agent 7.5%, revenue 1.6%. Mix: US and Canada (segment split not found).
  • RE/MAX Holdings (RMAX legacy): franchisor (RE/MAX, Motto Mortgage). FY25: total revenue $291.6M (βˆ’5.2%), ex-marketing funds $218.8M (βˆ’4.3%), adj. EBITDA $93.7M (32.1% margin), net income $8.2M, agents 148,660 total (+1.4%) but US/Canada 72,977 (βˆ’4.6%). FY26 guide adj. EBITDA $90–100M (pre-merger; guidance now suspended). Q2'26: revenue $68.5M (βˆ’5.8%), adj. EBITDA $22.9M (βˆ’12.6%), GAAP EPS βˆ’$0.20.
  • Combined: >180,000 agents, >100,000 in US/Canada, 120+ countries; pro forma 2025 revenue ~$2.3B and adj. EBITDA $157M (company; = $62.9M Real + $93.7M RMAX).
  • Economics: Real is a high-volume, low-margin gross-commission model (gross margin ~8–9%); RE/MAX is a high-margin (32%) royalty model. Combining them is the strategic bet: franchise cash flow funds a tech/agent-growth engine.
  • Moat: modest. Evidence for: brand (RE/MAX), agent-centric economics driving Real's 26% agent growth, 19% fall in adj. opex per transaction ($371 vs $459). Against: agents are portable, commissions are under legal/structural pressure, RE/MAX's US core is shrinking. Durability: low-to-medium.
  • Top customers/geographic split: not applicable (agents are customers); breakdown by country not found.

Financial trend

Combined-company quarterly history does not exist. Real standalone (USD M; Source: Real releases):

Period Revenue y/y Gross profit (margin) Op. income Adj. EBITDA (margin) Net income Op. cash flow Cash / debt
FY2025 ~2,000 +56% 165.7 n/f 62.9 (~3.1%) βˆ’8.1 n/f 49.9 / none
Q1'26 465.6 +32% 42.2 (9.1%) βˆ’3.4 14.9 (3.2%) n/f 23.3 62.9 / none
Q2'26 700.6 +30% 58.3 (8.3%) βˆ’7.0 27.6 (3.9%) βˆ’8.0 47.2 86.6 / none
RE/MAX standalone: FY25 adj. EBITDA 93.7; Q2'26 adj. EBITDA 22.9, revenue 68.5. Pre-merger debt β‰ˆ $437M term loan (per Inman, secondary source).
  • Gaps: Q3'25/Q4'25/Q2'25 quarterly details beyond Q2'25 (revenue $540.7M, adj. EBITDA $20.0M, gross profit $47.9M) not collected; FCF/capex, EPS history, SBC % of revenue (Q1'26 adj. EBITDA add-backs, SBC and other, β‰ˆ$17.0M per a secondary source) β†’ SBC % of revenue β‰ˆ 3.7% of Q1 revenue is an upper-bound including other items; not a clean figure. Share count history: not found (10-for-1 consolidation in Aug 2026 distorts it).
  • Post-close balance sheet: $550M secured term loan + $40M revolver (secondary sources: Inman/SEC summaries; terms/spread not confirmed). Target net debt/adj. EBITDA <2.0x by end of second full fiscal year post-close. Maturity date not found. Prior RE/MAX facility pricing was SOFR+2.50% (7.0% at end-2024) β€” new pricing not found.
  • Illustrative leverage: $550M / $157M β‰ˆ 3.5x gross, before synergies and before cash (cash post-close not found).
  • ROIC vs cost of capital: not computable with confidence; ROIC on the $880M EV acquisition β‰ˆ $157M EBITDA... after SBC, tax and capex likely low-double-digit at best vs ~10–12% cost of equity for a levered small cap (Interpretation: roughly equal; synergies are what create value).

Track record

  • Q1'26 (reported 2026-05-07): revenue $465.6M vs ~$476.5M expected β†’ miss (secondary source); adj. EBITDA +80% y/y; stock dipped.
  • Q2'26 (reported ~Aug 2026): revenue $700.6M (+30%); consensus not found; adj. EBITDA +38%; opex/transaction βˆ’19%.
  • Real gives no formal guidance, so guidance accuracy cannot be graded. RE/MAX's FY26 guide ($90–100M) was suspended after Q2; Q2 EBITDA ran at ~$22.9M Γ—4 β‰ˆ $92M annualised, the low half.
  • Tone: Real = confident ("double-digit organic growth despite market near trough"). RE/MAX = no call, no guidance (a quiet-period signal, not negative per se).
  • Recurring Q&A themes (inferred from coverage, call transcripts not accessible – blocked 403): synergies, leverage, agent attrition, gross-margin drift from capped agents.

Investment Score β€” **56 / 100 (fair)**

Sub-score Weight Score Rationale
Business quality & moat 20% 55 Real is a growth share-taker; RE/MAX brand is fading in US.
Growth 20% 70 Real +30% rev / +26% agents; RE/MAX βˆ’6%; blended organic mid-single-to-low-double digit.
Financial strength 15% 38 ~3.5x gross leverage, GAAP losses at Real, previously debt-free Real now levered.
Valuation 20% 72 ~7x adj. EBITDA on gross debt, but adj. EBITDA flatters (SBC).
Management & capital allocation 15% 55 Execution on Real is strong; a levered mega-deal plus a $450M buyback authorization simultaneously is contradictory.
Sentiment & momentum 10% 25 βˆ’62% y/y, βˆ’31% in a month, AI fears, proration overhang.
Weighted: 11.0+14.0+5.7+14.4+8.25+2.5 = 55.9 β†’ 56.

Risk Score β€” **68 / 100 (high)**

Risk Likelihood Impact Mitigation
Leverage / refinancing ($550M secured) Medium High Synergies, FCF, revolver; stated <2.0x target
Housing volume stays near trough / rates Medium High Real's agent growth is share-driven
RE/MAX franchise attrition (US βˆ’4.6%) High Medium Real tech platform, Aspire incentives
Integration / agent culture clash (two different models) Medium High Brands kept separate (unverified)
AI disintermediation of agents Low–Medium High None evident; narrative risk is immediate
Commission-structure litigation/regulation (post-NAR settlement) Medium Medium Not quantified
Dilution via SBC/equity plans & overhang from cash-out holders Medium Medium Buyback authorization
Small-cap volatility / liquidity High Medium Position sizing

36-month upside

Assumptions (all my judgements, flagged as such; shares ~36–37M base, ~34M bull with buybacks; no dividend assumed β€” dividend policy not found; interest assumed ~7–8% on debt):

Scenario 2028 revenue 2028 adj. EBITDA Net debt at exit Exit EV/EBITDA Equity / share Prob
Bear ~$2.2B (flat) $140M (franchise attrition, no synergies) ~$520M 5.0x $5.0 30%
Base ~$2.6B $205M (incl. ~$30M synergy, modest housing recovery) ~$390M 6.0x $22.7 50%
Bull ~$3.0B $270M ~$250M 8.0x $50.0 20%
Weighted $22.9 β†’ +40% vs $16.28 β†’ Upside Score band 30–60% β†’ 62.
  • Reverse DCF (simple): EV β‰ˆ $590M + $550M gross debt β‰ˆ $1.14B (cash not netted: unknown). If FCF to firm = adj. EBITDA $157M less ~$40M SBC-like cost, ~$20M tax, ~$15M capex β‰ˆ $80M, a 10% WACC zero-growth perpetuity = $0.8B; the price implies only ~3–4% perpetual growth and zero synergy credit. I.e. the market is pricing roughly the status quo with heavy risk discount. Caveat: my cost inputs are assumptions.

Management vs Wall Street

Metric Management Consensus Gap
Synergies ~$30M run-rate not found n/a
FY26 EBITDA no formal guidance (RE/MAX $90–100M withdrawn) not found n/a
Leverage <2.0x by end of year 2 not found n/a
Price target – TipRanks avg $26 (high $40, low $3 β€” stale mixed data); Jones $40; BTIG $35 PT β‰ˆ 60–145% above price
  • Credibility: Real has no guidance history to grade; CEO Tamir Poleg delivered 26–31% agent growth three years running (2025: +31%).
  • Incentives: not researched (proxy for new entity not yet filed β†’ not found).
  • Insiders: only Form 4 found = a trust gift/inheritance of 6,742 shares (non-market). No open-market insider buys/sells verified over 12 months β†’ not found.

Competitive landscape

Peer Latest data Note
Compass (incl. Anywhere) Q2'26 revenue $4.31B (+109%; +14.3% pro forma), adj. EBITDA $363M, 83,184 US agents, net income $92M, LT debt $3.14B, synergies target $500M Largest; gaining share (pro forma transactions +7.4% vs market ~3.5%)
eXp World Q2'26 revenue ~$1.4B (+11%), adj. EBITDA $25.7M, 87,338 agents (+6%) β€” secondary source, unverified Most direct revenue-share peer
REAX combined ~$2.3B pro forma, $157M adj. EBITDA, >100K US/Canada agents Franchise + brokerage hybrid
Peer valuation multiples and 5-year historical ranges: not found. Market-share: Real ~62K closed sides/quarter; US share not found. Substitutes: AI search/iBuyers/discount brokers – qualitative only.

Capital allocation

Buyback authorization $450M / ≀25M shares (no expiry). Dividend: RE/MAX historically paid; combined policy not found. M&A: the RE/MAX deal ($880M EV, 5.15x cash-adjusted / 0.515 shares or $4.33 + 0.3535 shares after proration; ~$80M cash to RMAX holders). Capex intensity low (capex figures not found). Dilution: Real's SBC/equity-plan costs sit inside adj. EBITDA add-backs; plus new shares issued to RMAX holders.

Ownership & sentiment

Insiders: see Β§11. Institutions: 25 hedge funds at end of Q2 (up from 21), Wasatch Long/Short held a short. Short interest: conflicting (8.4% of float Sept per Equibles; 11.9% Finviz; 16.5% older ChartMill); days-to-cover not found. Ratings: mostly Buy (JonesTrading Buy $40 on 2026-09-15; Public.com: 6 analysts Strong Buy). Momentum: βˆ’61.8% 1Y, βˆ’30.9% 1M (as of 2026-09-16), well below the index.

Catalyst calendar (next 12 months)

  • ~2026-10-28/29: Q3'26 results (first combined; date unconfirmed).
  • Q4 2026: buyback start; potential term-loan repricing.
  • ~Feb–Mar 2027: FY26 results + first FY27 outlook.
  • 2027: majority of $30M synergies; spring selling season.
  • Investor day: none found. Lock-ups/debt maturity dates: not found.

KPIs to track & thesis-breakers

KPI Current Confirm Break
Real agents 35,348 (Q2'26) >+15% y/y <+10% y/y
Combined agents >180K β‰₯185K <170K
RE/MAX US/Canada agents 72,977 (FY25) decline <3% decline >8%
Adj. EBITDA (combined) $157M (2025 PF) β‰₯$40M/quarter <$32M/quarter
Net debt / adj. EBITDA ~3.5x gross (cash unknown) ≀3.0x by mid-27 >4.5x
Real gross margin 8.3% (Q2'26) β‰₯9% <8%
Synergies realised 0 β‰₯$15M run-rate by end-27 <$8M
GAAP operating income βˆ’$7.0M (Q2'26 Real) positive ex-deal costs negative 2 quarters in 2027

Portfolio fit (factual)

4.4% weight (joint-largest) vs risk score 68: above-average risk concentration relative to moderate-risk assets. Overlaps: consumer/rate-sensitive financials in portfolio (SOFI 1.1%, PGY 2.2%, NU 2.3%, RPAY 1.8%, FIGR 1.3% – housing/rates sensitivity partly shared via mortgage-rate channel, Interpretation). Little operational overlap with the energy/AI/commodity names.

Conclusion

The market is right that this is a levered, cyclical, integration-dependent equity with fading legacy franchise units and GAAP-light earnings. It may be underestimating the scale of the Real growth engine (Q2 revenue +30%, 35K agents), the synergy upside, and the equity convexity from deleveraging at ~7x EBITDA. Score 56: strong growth and cheap headline valuation offset by weak balance sheet, poor sentiment, and thin data. Upside +40% probability-weighted comes with a 30% chance of β‰ˆ βˆ’69%.

Confidence & data gaps

Overall confidence: Low–Medium. Gaps (all matter): share count (21.8M–36.3M across sources, I used implied 36.3M), post-close cash/net debt and loan terms, consensus estimates for FY26–28, SBC and FCF, insider transactions, peer multiples, 5-year valuation ranges, earnings-call transcripts (403-blocked), Q2 consensus beat/miss, Real's Q2 call date vs Benzinga labelling. Several price-target aggregators show pre-consolidation values and were discarded.

Sources
  1. Real Brokerage Q2 2026 results β€” SEC (Form 6-K ex 99.5) β€” Aug 2026 β€” https://www.sec.gov/Archives/edgar/data/1862461/000149315226036250/ex99-5.htm
  2. Real Brokerage Q1 2026 results β€” Business Wire/Morningstar β€” 2026-05-07 β€” https://www.morningstar.com/news/business-wire/20260507655254/the-real-brokerage-inc-announces-first-quarter-2026-financial-results
  3. Business combination completion (Ex 99.1) β€” SEC β€” 2026-08-24 β€” https://www.sec.gov/Archives/edgar/data/0001862461/000110465926100333/tm2623609d5_ex99-1.htm
  4. Inman, deal mechanics (debt, buyback, close) β€” Inman β€” 2026-08-26 β€” https://www.inman.com/2026/08/26/real-remax-group-merger-deal-sec-filings-debt-buyback/ (via search summary; page blocked)
  5. RE/MAX Q2 2026 results β€” RE/MAX News/PR β€” 2026-08-06 β€” https://news.remax.com/press-release/re-max-holdings-inc-reports-second-quarter-2026-results (headline/summary only)
  6. RE/MAX FY2025 results & 10-K β€” Nasdaq/SEC β€” 2026-02-19 β€” https://www.nasdaq.com/press-release/re-max-holdings-inc-reports-fourth-quarter-and-full-year-2025-results-2026-02-19
  7. Real Brokerage FY2025 results β€” Yahoo/Business Wire β€” 2026-03-04 β€” https://finance.yahoo.com/news/real-brokerage-inc-announces-fourth-120000933.html
  8. Wasatch letter / REAX weakness β€” Yahoo Finance β€” 2026-09-16 β€” https://finance.yahoo.com/markets/stocks/articles/real-remax-group-reax-stock-130724417.html
  9. Cash proration / stock drop β€” HousingWire, Inman β€” Aug 2026 β€” https://www.housingwire.com/articles/remax-cash-proration-real-merger/
  10. Buyback β€” TipRanks/Investing.com β€” Aug 2026 β€” https://www.investing.com/news/company-news/real-remax-group-authorizes-450-million-share-buyback-program-93CH-4874205
  11. JonesTrading maintained Buy β€” GuruFocus β€” 2026-09-15 β€” https://www.gurufocus.com/news/9091566/reax-maintained-by-jones-trading-rating-remains-buy
  12. REAX analyst targets β€” TipRanks β€” 2026 β€” https://www.tipranks.com/stocks/reax/forecast
  13. Price/market cap β€” Yahoo Finance β€” 2026-10-07 β€” https://finance.yahoo.com/quote/REAX/
  14. Compass Q2 2026 β€” HousingWire/PR Newswire β€” 2026-08-04 β€” https://www.housingwire.com/articles/compass-q2-2026-revenue-anywhere/
  15. eXp Q2 2026 β€” MarketBeat β€” 2026-08 β€” https://www.marketbeat.com/earnings/reports/2026-8-7-exp-world-holdings-inc-stock/ (unverified)
  16. Short interest β€” Equibles/Finviz/ChartMill β€” Sep 2026 β€” https://equibles.com/stocks/reax/summary
All REAX Bulls vs Bears reports
Disclaimer. AI-generated research and podcast (Claude by Anthropic, voices by Google Gemini) for educational purposes β€” not financial advice and not a recommendation to buy or sell. Willem (MR.INVEST) owns this stock. Check the company’s own filings before making any decision.
← All Bulls vs Bears reports
REAX Bulls vs Bears β€” Stock Analysis β€” MR.INVEST